Location History:
- Palo Alto, CA (US) (2024)
- San Mateo, CA (US) (2024)
Years Active: 2024
Title: Innovations by Daniel Francisco Uribe
Introduction
Daniel Francisco Uribe is an inventive mind based in Palo Alto, CA, who has made significant contributions to the field of biospecimen tracking and privacy-preserving technologies. With a total of 2 patents, Uribe is at the forefront of innovations that aim to enhance privacy and data governance in genetic testing.
Latest Patents
Uribe's latest patents include a groundbreaking system and processes for anonymous DNA/RNA biospecimen tracking for human families using filters and non-fungible tokens. This innovative process allows families to utilize an anonymous DNA/RNA biospecimen extraction kit that employs public key infrastructure, asymmetric encryption, and Non-Fungible Tokens from a public Blockchain or Distributed Ledger Technology. The goal is to create a Self-Sovereign DNA Fingerprint for each donor, enabling them to relate, claim ownership, consent to use, and establish biological relationships while keeping track of corresponding multi-omics data sets.
Another notable patent is the privacy-preserving DNA/RNA/microbiome/COVID-19 test kit kiosk and locker. This kiosk allows customers to purchase test kits in public places without revealing their identities. It pairs with a private digital wallet to store results data securely. The kiosk is equipped with various sensors, including a camera for scanning test kit information, GPS, and environment sensors, ensuring a comprehensive and secure testing experience.
Career Highlights
Throughout his career, Uribe has focused on developing technologies that prioritize user privacy and data security. His work has been instrumental in advancing the field of genetic testing and biospecimen management.
Collaborations
One of Uribe's notable collaborators is William Gregory Buchanan, with whom he has worked on various innovative projects aimed at enhancing privacy in biospecimen testing.
Conclusion
Daniel Francisco Uribe's contributions to the field of biospecimen tracking and privacy-preserving technologies highlight his commitment to innovation and user privacy. His patents represent significant advancements that could transform how individuals manage their genetic data.